Stocks / NASDAQ / TransCode Therapeutics Inc.

TransCode Therapeutics Inc.

Our Opinion

TransCode Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that they use animals for product testing.

“Treatment increased survival – 67% of the experimental animals survived for 12 weeks” Read the following article

Company Description

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Company Website: